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Abstract 
Purpose: Recovery is the predominant discourse within current UK drug policy, promoted as 
freedom from dependence. In support of such a policy driver, prison drug recovery wings have been 
piloted in ten prisons in England and Wales to address high drug prevalence rates in prisoner 
populations.  This article explores the development of these specialist wings within the context of 
wider developments to tackle reoffending among drug-using prisoners.   
Design/methodology/approach: The first part of the paper offers an analysis of the emergence of 
the recovery paradigm in the prison context through analysis of official policy documents. The 
second draws predominantly upon two process evaluations of the drug recovery wings, alongside 
literature on prison drug treatment. 
Findings: There is limited empirical evidence to inform the debate about whether prisons can 
provide settings to facilitate recovery from the effects of illicit drug use. What is available suggests 
that effective therapeutic environments for recovering drug users could be established within 
prisons. Key components for these appear to be sufficient numbers of staff who are competent and 
confident in providing a dual role of support and discipline, and a common purpose of all prisoners 
committing to recovery from illicit drugs and supporting each other. Further research regarding the 
impact of drug recovery wings upon health, crime and wider social outcomes is needed.  
Originality/value: This paper provides an updated perspective on the development of drug 
treatment in prisons, with a particular focus on the implications of the new recovery paradigm.  
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Background 
There is extensive evidence to suggest that a significant proportion of the 85,892 prisoners in 
England and Wales (on 27th November 2015; Ministry of Justice, 2015a) have histories of using 
drugs. In addition, a considerable body of literature suggests that problem drug use is often related – 
albeit in a complex way – to offending behaviour (Bennett and Holloway, 2009; Hammersley, 2008).  
A survey of 1453 newly sentenced adult prisoners (Light et al., 2013) found that four-fifths had ever 
used drugs; almost two-thirds had done so in the four weeks before being imprisoned, and 
approximately half of these most recent drug users had taken a Class A drug (ecstasy, LSD, heroin, 
crack cocaine, cocaine and methadone). This recent drug user group were over twice as likely to 
reoffend within one year of their release (62% c.f. 30%). These data suggest high levels of problem 
drug use. Coupled with evidence of drug use in prison obtained via mandatory drug testing data (in 
place since 1996), drug seizure statistics and HM Inspectorate of Prison inspections, they suggest the 
need for a concerted effort to provide access to drug treatment for prisoners, alongside tackling the 
broader problems relating to drug use in prison. 
This has taken place over the past twenty years.  A series of strategies dating back to 1995 have 
sought to guide prisons in their responses to dealing with these issues. Prior to this, official reports 
pointed to the lack of drug treatment provision within prisons (ACMD, 1979; House of Commons 
Social Services Committee, 1985) and there was a reluctance to acknowledge the existence of a drug 
‘problem’ within prisons in England and Wales (Paylor et al., 2010). By the late 1980s the drug 
‘problem’ could no longer be denied. A growing evidence base demonstrating the nature and extent 
of drug use in prison, coupled with an emerging policy network drawing attention to the risk of 
prisoners transmitting the HIV virus to the general population, led to ‘the end of the denial’ (Duke, 
2003: 67).  
The first prison drug strategy - Drug Misuse in Prison: Policy and Strategy - was published in 1995 
(HM Prison Service, 1995) and updated three years later (HM Prison Service, 1998) so that it aligned 
with the first UK national drug strategy (President of the Council, 1998).  These strategic documents 
outlined a twin-track approach: aiming to reduce the demand for drugs within the prison whilst 
addressing the supply of drugs into the prison. Despite calls for harm minimisation as a pragmatic 
response, they focused on abstinence for fear of condoning illicit drug use. The harm reduction 
measures which were being rolled out in the community; for example, access to clean needles and 
substitute prescribing, were not offered in prisons. This represents one of the key tensions in prison 
drug policy, namely between treatment and punishment. We will return to this theme later in the 
article when we explore the challenges of tackling drug use in prison.  
In this short article, we look critically at the development of drug recovery wings in England and 
Wales over the past four years. Such wings were introduced into a number of prisons in 2011 and 
2012 to provide substance misusing prisoners with a drug treatment service focused on abstinence 
and recovery. First we will look at the origins of drug recovery wings; outlining the emergence of the 
‘new’ recovery paradigm in the UK, and drawing out its implications for prison drug policy and 
practice. Second, we will discuss the implementation of the drug recovery wings, highlighting the 
variation across the different pilot sites whilst also drawing upon the findings of two drug recovery 
wing process evaluation studies. Third, we will look at the particular challenges for developing drug 
recovery wings, noting in particular recent changes to the drug ‘problem’ within English and Welsh 
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prisons and also the changing context in which drug recovery wings operate. Finally, we will outline a 
future research agenda for exploring this promising but unproven intervention. 
The emergence of recovery  
As we have outlined above, the drugs ‘problem’ has traditionally been framed as one of order, 
control and discipline (see Duke, 2003), rather than in terms of treatment and the prevention of 
harm. Consequently, the first initiatives to manage the drug ‘problem’ included measures such as 
mandatory drug testing; a measure designed to discipline those who used drugs and in so doing 
deter others from doing so. This development has been subject to extensive research with mixed 
evidence regarding effectiveness (see Paylor et al., 2010 for an overview). There has been less 
emphasis upon supporting prisoners to address their drug use. Facilitated by three significant policy 
changes, the 2005 drug strategy (NOMS, 2005) placed a greater emphasis upon harm reduction 
whilst still maintaining a commitment towards supporting prisoners to become drug-free. The first 
was a shift of responsibility for prison health care provision from the Prison Service to the National 
Health Service (Department of Health and HM Prison Service, 2002). This facilitated the 
development of harm minimisation measures, including opiate maintenance prescribing as an 
important first step on a journey towards abstinence, but also Hepatitis B immunisation and blood-
borne virus testing (Marteau et al., 2010). The second was increased emphasis on using the 
opportunities offered by all stages of the criminal justice process to channel drug users into 
treatment (Kothari et al., 2002). Related to this, the final one was New Labour’s pursuit of the social 
exclusion agenda and recognition of the high rates of reoffending by prisoners, particularly those 
serving short sentences. Drugs and alcohol were included as one of the seven pathways in the 
Reducing Reoffending National Action Plan (Home Office, 2004). These developments led to the 
expansion of drug treatment within prison through the CARAT scheme (counselling, assessment, 
referral, advice and throughcare). Despite these efforts, it was noted in 2008 that access to drug 
treatment was patchy, not always of sufficient quality or appropriate, and not evidence-based 
(Pricewaterhouse Coopers, 2008). In response to this, a Prison Drug Treatment Strategy Review 
Group was convened in April 2009 to review evidence of effectiveness and make recommendations 
for change to promote the recovery and rehabilitation of drug users in prison and upon release 
(Patel, 2010). Around the same time, the Ministry of Justice published a Green Paper – ‘Breaking the 
Cycle: Effective Punishment, Sentencing and Rehabilitation of Offenders’ (Ministry of Justice, 2010). 
This consultation document announced plans to pilot drug recovery wings. It described drug 
dependency as ‘fuel[ling] crime’ (p.8) and argued that efforts were needed to support ‘offenders to 
get off drugs for good’ (p.27). 
 
The publication of the Patel report and the Green Paper formed part of a ‘new’ recovery agenda 
with a renewed focus on abstinence. Recovery is the predominant discourse in the 2010 drug 
strategy - ‘Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug 
Free Life’ (HM Government, 2010) - which was published by the newly formed Conservative- Liberal 
Democrat coalition Government shortly after its inception in May 2010.  In this document, it took on 
a specific meaning comprising of three principles: well-being, citizenship and freedom from 
dependence. Recovery and abstinence are not synonymous but have been treated as such as the 
debate about drug treatment has become more politicised (McKeganey, 2014). This is not 
necessarily unique to the UK or a recent phenomenon.  American commentators assert that there is 
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a long history of institutions characterizing the resolution of severe alcohol and other drug problems 
in moral (reformation), religious (redemption), psychological (reconstruction), criminal 
(rehabilitation), or medical (recovery, remission) language. They further assert that such institutions 
working within any of the stated paradigms tend to make strong claims regarding the origins of, and 
solutions for, drug dependence (White, 2005). In the UK context, the involvement of two think tanks 
– Centre for Policy Studies and Centre for Social Justice –  have been pivotal in advancing a recovery 
paradigm (see Wincup, 2013), and the latter have demonstrated a particular interest in what they 
refer to as ‘drug-fuelled prisons’ (Centre for Social Justice, 2015: 11).  
In other contexts, recovery has a different meaning, placing the service user at the centre of their 
treatment and attempting to bridge the harm reduction/abstentionist divide (Kidd, 2010). Its origins 
lie in the field of mental health, and as an organising principle for treatment services in the UK and 
beyond, the focus has been on the process of recovery i.e. promoting it as an active and 
empowering one for the service user rather than specifying what recovery is and how it might be 
achieved (see Thom, 2010). In contrast, a rather more prescriptive approach has been outlined for 
prisoners (see Patel, 2010: 8) which calls upon drug users ‘to actively engage with and assume 
responsibility for their own recovery, including a renewed focus on abstinence as a clear goal’. In 
‘Putting Full Recovery First’ (Home Office, 2012), the clinical guidance published five years previously 
was emphasised, which stated that ‘prisoners spending any significant period in custody will be 
stabilised, safely detoxified and released into the community drug free’ (p.21). 
Unlike its predecessors there was less emphasis in the 2010 drug strategy on breaking the drug-
crime link (Duke, 2013; Monaghan, 2012), but some attention was paid to how the criminal justice 
system might work most effectively with drug-using offenders. Specifically, in relation to prisoners, it 
introduced a series of pilots of abstinence-focused drug recovery wings. Given what we have noted 
already about the challenges of acknowledging the drug ‘problem’ within prisons and responding to 
it in a way which does not appear to threaten ord r and control, we can appreciate why a 
concentration on abstinence might be favoured within the prison context. It appears to ‘square the 
circle’ between treatment and punishment by addressing drug dependence whilst not condoning 
drug use. Addressing drug dependence then feeds into positive outcomes such as reduced 
reoffending, which has been a priority of successive Governments over the past two decades. 
Recovery is referred to in the 2010 drug strategy in high-level terms i.e. in terms of freedom from 
dependence, well-being and citizenship, but there is also an attempt to operationalise this through 
emphasising that achieving and sustaining recovery requires drug users to establish recovery capital 
(social, physical, human and cultural, see Best and Laudet, 2010 for an overview of the concept).  
This has significant implications for work with drug-using prisoners who typically have low levels of 
recovery capital and experience problems which are likely to make it difficult for them to recover; 
for example, poor mental health, lack of access to suitable housing and limited work histories 
(Hopkins, 2012; Light et al., 2013; Williams et al., 2012). There is also a growing appreciation of the 
need to recognise that the nature and extent of recovery capital may differ for females and males 
(Neale et al., 2014; Thom, 2010; Wincup, 2016). 
The next section explores the emergence of drug recovery wings in 10 prisons in England and Wales. 
It draws upon the only published evaluation studies of prison recovery wings (Lloyd et al., 2014; 
Powis et al., 2014) to explore whether such developments can offer an opportunity for prisoners to 
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‘recover’, and overcome some of the difficulties which have been associated with the delivery of 
prison-based drug treatment in the past. Both studies used semi-structured interviews to gather 
qualitative data from prisoners and drug recovery wing staff at the pilot sites. Powis et al. (2014) 
evaluated the first tranche of pilot sites and in total interviewed 36 members of the drug recovery 
wing staff, 16 members of staff from the wider establishment, 12 partnership staff members, 44 
current prisoner drug recovery wing participants and 6 drug recovery wing participants who did not 
complete the regime. These interviews took place between November 2011 and June 2012, whilst 
the drug recovery wings were still in the early stages of implementation. Lloyd et al.’s (2014) rapid 
assessment focused on all 10 of the pilot sites, interviewing 102 prisoner drug recovery wing 
participants overall and 97 members of staff across the sites. These interviews were conducted in 
2013. 
The emergence of drug recovery wings 
The first wave of pilot drug recovery wings were introduced into HMP Bristol (category B male), 
Brixton (category C/D male), High Down (category B male), Holme House (category B male) and 
Manchester (category A male) in June 2011 (Policy Innovation Research Unit, 2012). The second 
tranche were launched in the remaining five prisons in April 2012; HMP Chelmsford (category B 
male), New Hall (closed female), Styal (closed female), Swansea (category B male) and Brinsford 
(male young offenders) (Lloyd et al., 2014). The specific aim of these drug recovery wings was 
identified to move those with substance misuse problems from dependence towards full recovery 
from their addiction through the provision of intensive support. The need to improve continuity of 
care between prisons and the community was also emphasised (Powis et al., 2014).  
Although the drug recovery wings have the same overarching aims, there is considerable variation in 
how they are run in each prison. Pilot prison sites were encouraged to develop their own drug 
recovery wing model based upon the needs of the local population they would be serving, and the 
environment of the establishment in which they were located (Lloyd et al., 2014). As such, there is 
no universal mechanism for selecting participants onto the drug recovery wings, however most of 
the sites emphasised the importance of prisoners being motivated to change and move towards 
abstinence as criteria for suitability to be placed on the drug recovery wings (Lloyd et al., 2014). 
There is also considerable variation in the length of time participants spend on the drug recovery 
wings; for example, participants at HMP Bristol reside on the wing for approximately 28 days before 
being moved on (either released or moved to another wing within the establishment), whilst those 
at HMYOI Brinsford were able to reside on and receive the drug recovery wing services for up to two 
years (Lloyd et al., 2014). The range of services provided at the pilot sites are also very different but 
generally include the following; pharmacological services, psychosocial services such as SMART 
recovery groups and one-one sessions with key workers, mutual aid groups such as Narcotics 
Anonymous and Alcoholics Anonymous, and holistic services such as life skills group sessions, 
education/employability sessions, extra gym sessions, acupuncture and yoga (this list is not 
exhaustive, please see Lloyd et al., 2014 for full list of services provided at each of the drug recovery 
wing sites). In line with the aim to improve continuity of care between prisons and the community, 
the majority of the pilot drug recovery wings also provide ‘through the gate’ services. Such services 
include housing and employment initiatives, access to a family support worker, pre-release meetings 
with community agencies and escorting participants to community appointments post-release (Lloyd 
et al., 2014). The pilots recognised – to differing extents – that efforts are needed to allow drug 
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users to establish different forms of recovery capital to help them achieve, and crucially sustain, full 
recovery.  The available evidence on drug recovery wings suggests that some have at least taken 
steps to allow prisoners to build upon their low levels of recovery capital.   
Relationships between prisoners and staff on the wing are crucial to building recovery capital. Both 
Powis et al. (2014) and Lloyd et al. (2014) found that prisoners, prison officers and the drug recovery 
wing non-custodial staff perceived the prisoner-staff relationships on the drug recovery wing to be 
overwhelmingly positive. A large proportion of prisoners interviewed highlighted the high levels of 
support provided by the specialist prison officers on the drug recovery wing, with many suggesting 
that they are much more supportive than the officers from the mainstream wings within the 
establishment. Thus is captured in the following quote “other wings, it’s clearly us and them. Here 
there’s a family feeling” (Powis et al., 2014: 25). These positive prisoner-staff relationships could be 
explained by the fact that many of the prison officers on these wings have received specialist 
substance misuse training, and have volunteered for or been selected for the role based upon 
previous experience. Past research has indicated that specially trained substance misuse officers 
appear to be more supportive towards and hold less negative attitudes towards drug using prisoners 
than ‘mainstream’ prison officers (McIntosh and Saville, 2006). However, although both evaluation 
studies found that prison officers did concur that prisoner-prison officer relationships were good, a 
number of the prison officers interviewed in Lloyd et al.’s (2014) study did note the tension between 
care and discipline, and the difficulty of finding the correct balance between the two.  
Balancing care and discipline is a challenge for the prison system generally but is heightened on 
abstinence-focused drug recovery wings. Staff working on the wings have care and control functions 
which have typically been understood as the cause of antagonistic relationships between staff and 
prisoners.  To understand this further it is worth dwelling on who might comprise the staff on these 
wings. They include prison officers but also drug workers, and it is likely that these two categories of 
staff have different occupational identities which could potentially result in conflict between staff, as 
well as between staff and prisoners. Evidence from a research study conducted in Finland and 
Sweden (Kolind et al., 2015) found evidence of positive adaption with drug workers integrating and 
reinterpreting the control, order and disciplinary sanctions of the prison environment into their 
treatment approach. Conversely, officers highlighted the treatment ethos in their control work. It is, 
of course, foolish to assume that this will automatically be replicated within other jurisdictions, but 
does suggest that seemingly incompatible rationalities can co-exist in practice. Since the introduction 
of quasi-compulsory drug treatment for offenders following the 1998 drug strategy, community-
based drug workers in the UK have had to incorporate elements of control into their work with 
clients, as non-engagement and relapse potentially constitute a breach of their community sentence 
or licence conditions (see Hucklesby and Wincup, 2010). 
 
It was not only support from staff that was deemed important in working towards recovery on the 
drug recovery wings, but support amongst prisoners. In both of the evaluation studies, the majority 
of the prisoners interviewed felt they had been supported and encouraged by their peers on the 
wing, with staff and prisoners reporting a more relaxed, therapeutic environment with less bullying 
than that found on other wings within the establishment. Both prisoners and staff often referred to 
the drug recovery wing as having a sense of community whereby prisoners could support each other 
in their efforts towards achieving recovery. This community feel may have been facilitated by the 
drug recovery wings at each site being either partially or fully segregated from the wider prison, 
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thereby creating a supportive environment similar to those created by therapeutic community 
models. This may have been enhanced further by the numerous mutual aid sessions provided, such 
as the Narcotics Anonymous, Cocaine Anonymous and Recovery is Out There group sessions. Such 
mutual aid groups have been shown to have a positive impact on substance misuse outcomes (NTA, 
2013), particularly when accessed alongside the provision of a structured treatment programme 
(Fiorentine and Hillhouse, 2000). One issue related to peer support on the drug recovery wings was 
the placement of ‘lodgers’; those placed on the wing due to capacity or high risk issues rather than 
to access the different substance misuse services. Research by Lloyd et al. (2014) and Powis et al. 
(2014) found that staff and prisoners on the drug recovery wing perceived lodgers to be problematic, 
impacting upon the therapeutic environment of the wing and taking up spaces which should be 
reserved for those prisoners wanting to recover from their dependency. This suggests that in order 
to keep the strong therapeutic, community feel which prisoners on the wing perceive to be an 
important aspect, prison managers should, wherever possible, ensure that only substance- misusing 
offenders ready to engage with drug recovery services should be placed on the drug recovery wings.  
 
A further challenge to the long-term effectiveness of drug recovery wings is that prisoners are 
accommodated for only a short period of time, hence their effectiveness hinges upon the 
relationships established with other services offered in the prisons and the quality of partnership 
working. The literature on resettlement identifies the challenges of realising this in practice 
(Hucklesby and Hagley-Dickinson, 2007). The range of services provided in prisons by statutory, 
private, voluntary and community sector organisations offers the opportunity to embrace a holistic 
approach to recovery, but to work effectively requires considerable co-ordination and positive 
working relationships between the key players. A further consideration is that prisoners may be 
‘resettled’ to other parts of the prison rather than released straight into the community. Where they 
are subsequently housed is crucial, particularly given recent concerns about drug availability in 
prisons which we will explore in the next section of the article. The second annual review of the 
2010 drug strategy (HM Government, 2013) stated that five drug-free wings were being piloted to 
support ‘recovered’ prisoners, as well as prisoners who had never had a drug problem. The third 
annual review (HM Government, 2015) called for their expansion. Crucially, drug recovery wings can 
only provide part of the solution to rehabilitating drug-using offenders and there needs to be a 
prison-wide commitment to recovery. 
Although research by Lloyd et al. (2014) and Powis et al. (2014) found some initial positive findings 
regarding the pilot drug recovery wings in terms of positive prisoner-staff relationships and high 
levels of peer support, it is important to note that they were process evaluations and therefore 
unable to evaluate whether drug recovery wings have actually led to behaviour change and 
reductions in drug use and re-offending. Similarly, recent HM Inspectorate of Prison reports have 
identified potential good practice but without being able to point to evidence of effectiveness (HM 
Chief Inspector of Prisons, 2014a; 2014b; 2015a). Therefore, further research is required to explore 
whether drug recovery wings can support drug users achieve recovery whilst in prison which lead to 
sustained reductions in drug use and reoffending upon release. Such research has been 
commissioned by the Department of Health and is currently underway at a number of the pilot sites 
(Lloyd et al., 2014). Despite being unable to draw any firm conclusions until the completion of this 
evaluation, approximately 35 ‘unofficial’ drug recovery wings not part of the pilot programme have 
been set up in prisons across England and Wales (Centre for Social Justice, 2015). 
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Challenges for Drug Recovery Wings 
In the short space of time since drug recovery wings have been introduced, there have been 
noteworthy changes to the nature of the drug ‘problem’ in UK prisons. In consecutive annual reports, 
HM Inspectorate of Prisons observed that diversion of prescribed medication previously reported in 
high security and vulnerable prison populations was now a major concern in the majority of prisons 
inspected, yet largely undiscovered via random or ‘reasonable suspicion’ drug testing (HM 
Inspectorate of Prisons, 2012; 2013. See also Public Health England, 2013). Aside from the health 
risks associated with taking medication prescribed for another person (for example, overdose or 
possible interactions with other prescribed medication), diverted prescription drugs are associated 
with drug debts and bullying, placing individuals at risk and undermining attempts to establish 
prisons as safe places to live and work. By 2014-15, the main concern of HM Inspectorate of Prisons 
(2015) was novel psychoactive substances (NPS), such as ‘Spice’ and ‘Black Mamba’, having noted 
the previous year that they were an emerging problem in adult male establishments, particularly 
local (i.e. for remand or newly sentenced prisoners) and Category D (i.e. open) prisons (HM 
Inspectorate of Prisons, 2014). Again the links between these drugs and threats to safety was 
emphasised by their unpredictable and potentially life-threatening effects. A recent Prisons and 
Probation Ombudsman report further highlighted the life-threatening effects of NPS, with NPS 
suggested to be implicated in the deaths of 19 prisoners between April 2012 and September 2014 
(Prisons and Probation Ombudsman for England and Wales, 2015). Growing demand for these 
substances is believed to be part of the explanation for the rising number of drug seizures over the 
past three years (Johnston, 2015). Again, use of these drugs is not picked up via drug testing, giving 
the misleading impression that drug use in prisons is continuing to fall. Addressing the potential 
harms caused by the unexpected increase in NPS use in the prison estate is a significant challenge 
for drug recovery wings. 
Not only has the nature of the drug problem in prisons changed since the introduction of the pilot 
drug recovery wings, but also the wider prison context in which they operate. From June 2013 to 
present, the prison population has increased by approximately 1% per year (Ministry of Justice, 
2015b), and in 2014 it was reported by the Ministry of Justice that out of the 118 prisons in England 
and Wales, 80 were found to be overcrowded (Ministry of Justice, 2014). As prisons are becoming 
increasingly overcrowded it is questionable, given the limited capacity of prison establishments, 
whether prisons are able to have a separate and distinct drug recovery wing where only substance 
misusing prisoners engaging with the programme are located. The research of Lloyd et al. (2014), 
Powis et al. (2014) and a recent unannounced inspection at HMP Bristol (HM Chief Inspector of 
Prisons, 2015b) has highlighted that such has already been found to be challenging in the pilot sites, 
as it was reported at the sites that non-treatment prisoners were being placed on the wing due to a 
shortage of space elsewhere in the prisons. As mentioned in the previous section, this placement of 
non-drug recovery wing prisoners on the wings may be problematic in terms of negatively impacting 
upon the strong therapeutic environment apparent on such wings (Lloyd et al., 2014; Powis et al., 
2014; HM Chief Inspector of Prisons, 2015b). 
Whilst the prisoner population has risen, between 2010 and 2014, the number of public sector 
prison officers in post has reduced by 29%, from 45,080 to 32,100 (HM Inspectorate of Prisons, 
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2015). This reduction in prison officer numbers is partly a result of the benchmarking process 
introduced into public sector prisons in 2013 (House of Commons Justice Committee, 2015), with 
such a process aiming to make efficiency savings and ensure the competitiveness of public sector 
prisons are comparable with those of commercial organisations. As staffing represents one of the 
major prison costs, it is of no surprise that one outcome of benchmarking has been to alter staffing 
complements and run the service on a reduced staff resource (House of Commons Justice 
Committee, 2015). The negative impact on staff-prisoner ratios resulting from this process may be 
detrimental to drug recovery wings, as the new prison officer staffing levels on such wings may not 
be sufficient to conduct therapeutic work and run the drug recovery regime efficiently and safely. 
Recent HM Inspectorate of Prisons reports have indicated that such may the case. In HMP Brixton it 
was reported that recent staff shortages had led to a reduction in the number of drug tests being 
completed on the drug recovery wing (HM Chief Inspector of Prisons, 2015c), whilst in HMP Bristol 
prison officer supervision of the medication queue on the wing was found to be insufficient, 
resulting in a loss of privacy and an increased risk of diversion of medication (HM Chief Inspector of 
Prisons, 2015b). The impact of reduced staff numbers as a result of benchmarking was also 
expressed by staff as a major concern by Lloyd et al. (2014), which reported that a number of staff 
felt this process undermined the work of the pilot drug recovery wings.  
Conclusion 
In summary, common findings from the limited published evidence to date would suggest that a 
therapeutic environment can be provided within prison settings to support prisoners recover from 
illicit drug use. Key components for such an environment appear to be sufficient numbers of 
discipline staff who are competent and confident in providing a dual role of support and discipline, 
and a common purpose of all prisoners committing to recovery from illicit drugs and supporting each 
other to do so. Many unanswered questions remain which form areas for future research activity. 
Crucially, further research regarding the impact of drug recovery wings upon health, crime and wider 
social outcomes (for example, housing and employment) are needed. Key questions are whether 
commitment to the programme found on drug recovery wings leads to sustained behaviour change 
following prison release and reduced levels of illicit drug use, reduced re-offending behaviour and 
reduced social exclusion. Furthermore, it remains unclear whether therapeutic environments within 
the prison need to be distinct locations, or whether the therapeutic concept of recovery can be 
applied across the whole prison estate. This is of crucial importance since the prison population in 
England and Wales is rising, and therefore “stand-alone” drug recovery wings could increasingly be 
difficult to access given the large proportion of the prisoner population with a history of drug 
dependence. Finally, it is important to note that the culture of drug taking is subject to rapid change 
and these are likely to have an impact upon whether the prison can operate effectively as a recovery 
setting. For example, as we have discussed there is increasing UK evidence regarding the growing 
prevalence of NPS misuse in English and Welsh prisons, and emerging evidence regarding the abuse 
of prescribed medication within prison settings. Therefore, whilst the key components of a 
therapeutic recovery programme in prison may not change, their application to specific and rapidly 
changing drug-using norms may well require modification.  
 
 
Page 9 of 14 Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
Acknowledgements 
All authors declare that they have no conflicts of interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 10 of 14Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
References 
ACMD. (1979), Report on drug dependents within the prison system in England and Wales, Home 
Office, London. 
 
Bennett, T. and Holloway, K. (2009), “The causal connection between drug misuse and crime”, British 
Journal of Criminology, Vol. 49 No.3, pp.513-531. 
 
Best, D. and Laudet, A. (2010), The potential of recovery capital, Royal Society of Arts, London. 
Centre for Social Justice. (2015), Drugs in prison, The Centre for Social Justice, London.  
 
Department of Health and HM Prison Service. (2002), Developing and modernising primary care in 
prisons, Department of Health, London.  
 
Duke, K. (2003), Drugs, prisons and policy-making, Palgrave Macmillan, London. 
 
Duke, K. (2013), “From crime to recovery: the reframing of British drug policy”, Journal of Drug Issues, 
Vol. 43 No.1, pp.39-55. 
 
Fiorentine, R. and Hillhouse, M.P. (2000), “Self-efficacy, expectancies, and abstinence acceptance: 
further evidence for the addicted-self model of cessation of alcohol – and drug-dependent 
behaviour”, American Journal of Drug and Alcohol Abuse, Vol. 26 No. 4, pp.497-521. 
 
Hammersley, R. (2008), Drugs and crime: theories and practices, Polity Press, Cambridge. 
 
HM Chief Inspector of Prisons. (2014a), Report on an unannounced inspection of HMP/YOI 
Chelmsford, HM Inspectorate of Prisons, London. 
 
HM Chief Inspector of Prisons. (2014b), Report on an unannounced inspection of HMP & YOI Styal, 
HM Inspectorate of Prisons, London. 
 
HM Chief Inspector of Prisons. (2015a), Report on an unannounced inspection of HMP & YOI New 
Hall, HM Inspectorate of Prisons, London. 
 
HM Chief Inspector of Prisons. (2015b), Report on an unannounced inspection of HMP Bristol, HM 
Inspectorate of Prisons, London. 
 
HM Chief Inspector of Prisons. (2015c), Report on an unannounced inspection of HMP Brixton, HM 
Inspectorate of Prisons, London. 
 
HM Government. (2010), Drug strategy 2010, reducing demand, restricting supply, building recovery: 
supporting people to build a drug free life, Home Office, London. 
 
Page 11 of 14 Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
HM Government. (2013), Drug strategy: annual review: delivering within a new landscape, HM 
Government, London. 
 
HM Government. (2015), Drug strategy 2010: ‘a balanced approach’: third annual review, HM 
Government, London. 
 
HM Inspectorate of Prisons. (2012), HM Chief Inspector of Prisons for England and Wales annual 
report 2011-12, The Stationery Office, London. 
 
HM Inspectorate of Prisons. (2013), HM Chief Inspector of Prisons for England and Wales annual 
report 2012-13, The Stationery Office, London. 
 
HM Inspectorate of Prisons. (2014), HM Chief Inspector of Prisons for England and Wales annual 
report 2013-14, The Stationery Office, London.  
 
HM Inspectorate of Prisons. (2015), HM Chief Inspector of Prisons for England and Wales annual 
report 2014-15, The Stationery Office, London.  
 
HM Prison Service. (1995), Drug misuse in prison, HMSO, London.  
 
HM Prison Service. (1998), Tackling drugs in prison: the Prison Service drug strategy, HMSO, London. 
 
Home Office. (2004), Reducing reoffending national action plan, Home Office, London. 
 
Home Office. (2012), Putting full recovery first, HM Government, London. 
 
Hopkins, K. (2012), The pre-custody employment, training and education status of newly sentenced 
prisoners: results from the surveying prisoner crime reduction (SPCR) longitudinal cohort study of 
prisoners, Ministry of Justice, London. 
 
House of Commons Justice Committee. (2015), Prisons: planning and policies. Ninth report of session 
2014-15, The Stationery Office, London. 
 
House of Commons Social Services Committee. (1985), Fourth report from the Social Services 
Committee, misuse of drugs with special reference to the treatment and rehabilitation of misusers of 
hard drugs, session 1984/85, HMSO, London. 
 
Hucklesby, A. and Hagley-Dickinson, L. (2007), Prisoner resettlement: policy and practice, Willian 
Publishing, Devon. 
 
Johnston, C. (2015), “UK prison drug seizures on the rise”, The Guardian, 17
th
 January 2015, available 
at: http://www.theguardian.com/society/2015/jan/17/uk-prison-drug-seizures-on-rise (accessed 5 
November 2015). 
 
Kidd, B. (2010), “Treatment and recovery: anything new under the sun?”, in Barlow, J. (Ed.), 
Substance misuse: the implications of research, policy & practice, Jessica Kingsley Publishers, 
London, pp.75-93.  
 
Page 12 of 14Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Kolind, T., Frank, V., Lindberg, O. and Tourunen, J. (2015), “Officers and drug counsellors: new 
occupational identities within Nordic prisons”, British Journal of Criminology, Vol. 55 No.2, pp.303-
320. 
 
Kothari, G., Marsden, J. and Strang, J. (2002), “Opportunities and obstacles for effective treatment of 
drug misusers in the criminal justice system in England and Wales”, British Journal of Criminology, 
Vol. 42 No.2, pp.412-432. 
 
Light, M., Grant, E. and Hopkins, K. (2013), Gender differences in substance misuse and mental health 
amongst prisoners: results from the surveying prisoner crime reduction (SPCR) longitudinal cohort 
study of prisoners, Ministry of Justice, London. 
 
Lloyd, C., Page, G., Russell, C., McKeganey, N. and Liebling, A. (2014), “Evaluation of the drug 
recovery wing pilots: scoping and feasibility report”, available at: 
https://www.york.ac.uk/healthsciences/research/mental-
health/projects/drugrecoverywingpilotsevaluation/#tab-3 (accessed 16 July 2015).  
 
Marteau, D., Palmer, J. and Stöver, H. (2010), “Introduction of the Integrated Drug Treatment 
System (IDTS) in English prisons”, International Journal of Prisoner Health, Vol. 6 No. 3, pp.117-124. 
 
McIntosh, J. and Saville, E. (2006), “The challenges associated with drug treatment in prison”, 
Probation Journal, Vol. 53 No. 3, pp.230-247. 
 
McKeganey, N. (2014), “Clear rhetoric and blurred reality: the development of a recovery focus in 
drug treatment policy and practice”, International Journal of Drug Policy, Vol. 25 No. 5, pp.957-963. 
 
Ministry of Justice. (2010), Breaking the cycle: effective punishment, rehabilitation and sentencing of 
offenders, Ministry of Justice, London. 
 
Ministry of Justice. (2014), Prison population monthly bulletin September 2014, Ministry of Justice, 
London. 
 
Ministry of Justice. (2015a), Population bulletin: weekly 27 November 2015, Ministry of Justice, 
London. Available at: https://www.gov.uk/government/statistics/prison-population-figures-2015 
(accessed 5 November 2015). 
 
Ministry of Justice. (2015b), Offender management statistics bulletin, England and Wales: Quarterly 
April to June 2015, Ministry of Justice, London. 
 
Monaghan, M. (2012), “The recent evolution of UK drug strategies: from maintenance to behaviour 
change?”, People, Place and Policy Online, Vol. 6 No.1, pp.29-40. 
 
National Treatment Agency. (2013), Helping clients to access and engage with mutual aid: turning 
evidence into practice, National Treatment Agency for Substance Misuse, London.  
 
Neale, J., Nettleton, S. and Pickering, L. (2014), “Gender sameness and difference in recovery from 
heroin dependence: a qualitative exploration”, International Journal of Drug Policy, Vol. 25 No. 1, 
pp.3-12. 
NOMS. (2005), Strategy for the management and treatment of problematic drug users within the 
correctional services, Home Office, London. 
Page 13 of 14 Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
Patel, Professor Lord. (2010), The Patel report: prison drug treatment strategy review group: 
reducing drug-related crime and rehabilitating offenders, HM Prison Service, London. 
 
Paylor, I., Hucklesby, A. and Wilson, A. (2010), “Drug interventions in prisons”, in Hucklesby, A. and 
Wincup, E. (Eds.), Drug interventions in criminal justice, Open University Press, Maidenhead, pp.190-
216. 
 
Policy Innovation Research Unit. (2012), Advisory note to the Department of Health on the 
evaluation of the drug recovery wing pilots programme, Policy Innovation Research Unit, London. 
 
Powis, B., Walton, C. and Randhawa, K. (2014), Drug recovery wings set up, delivery and lessons 
learned: process study of first tranche DRW pilot sites, NOMS, London.  
 
President of the Council. (1998), Tackling drugs to build a better Britain: the Government’s ten-year 
strategy for tackling drugs misuse, HMSO, London. 
 
Pricewaterhouse Coopers. (2008), Review of prison-based drug treatment: report to the Department 
of Health and Ministry of Justice, Ministry of Justice, London. 
 
Prisons and Probation Ombudsman for England and Wales. (2015), Learning lessons bulletin: fatal 
incident investigations issue 9, Prisons and Probation Ombudsman for England and Wales, London. 
 
Public Health England. (2013), Managing persistent pain in secure settings, Public Health England, 
London. 
 
Thom, B. (2010), “Women in recovery”, in Yates, R. and Malloch, M. (Eds.), Tackling addiction: 
pathways to recovery, Jessica Kingsley Publishers, London, pp.52-69. 
 
Wincup, E. (2013), Understanding crime and social policy, The Policy Press, Bristol. 
 
Wincup, E. (2016), “Gender, recovery and contemporary UK drug policy”, Drugs and Alcohol Today. 
 
White, W.L. (2005), “Recovery: its history and renaissance as an organizing construct concerning 
alcohol and other drug problems”, Alcoholism Treatment Quarterly, Vol. 23 No. 1, pp.3-15.  
 
Williams, K., Poyser, J. and Hopkins, K. (2012), Accommodation, homelessness and reoffending of 
prisoners: results from the surveying prisoner crime reduction (SPCR) survey, Ministry of Justice, 
London. 
 
Page 14 of 14Drugs and Alcohol Today
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
